| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2afec86507fc41d4fd24a6693763f876 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1647 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 |
| filingDate |
2002-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dd2d441771924b10fcd51273ec774c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_164d97bf70000229cda5e9b3fdc0992e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c1558c3ea041a937bde7d55c6990245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f83f3421440d448a6dd01395d7d63fe |
| publicationDate |
2003-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20030065831-A |
| titleOfInvention |
cyclosporin-containing sustained release pharmaceutical composition |
| abstract |
The present invention relates to sustained release pharmaceutical compositions containing cyclosporin. More specifically, the present invention provides a cyclosporin-containing sustained release pharmaceutical composition comprising essentially a biodegradable polymer and a cyclosporin and a release modulator encapsulated therein, wherein the release modulator comprises a hydrophilic release modulator and a lipophilic release modulator. It relates to a cyclosporin-containing sustained release pharmaceutical composition which is at least one component selected from. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009102121-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190119936-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009102121-A2 |
| priorityDate |
2002-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |